
Tilray TLRY
$ 0.83
-3.98%
Quarterly report 2024-Q4
added 01-10-2025
Country |
![]() |
IPO year |
2018 |
Industry |
Drug manufacturers |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Brendan Kennedy |
Employees in the company |
1 646 |
Shares |
618 M |
Market Cap[1] |
$ 513 M |
EBITDA (LTM) |
$ -105 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.